Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 11, Number 8—August 2005

Spoligotyping and Mycobacterium tuberculosis

Andrea Gori*Comments to Author , Alessandra Bandera*, Giulia Marchetti*, Anna Degli Esposti*, Lidia Catozzi*, Gian Piero Nardi*, Lidia Gazzola*, Giulio Ferrario*, Jan D.A. van Embden†, Dick van Soolingen†, Mauro Moroni*, and Fabio Franzetti*
Author affiliations: *University of Milan, Milan, Italy; †National Institute of Public Health and Environmental Protection, Bilthoven, the Netherlands

Main Article

Table 1

Characteristics of 148 patients with acid-fast bacilli in biologic specimens*

Age, y
Median (range) 34 (3–88)
Mean 39.3
Sex, no. (%)
Male 105 (70.9)
Female 43 (29.1)
Type of patient, no. (%)
Infectious diseases 124 (83.8)
Pneumology 10 (6.8)
Internal medicine 10 (6.8)
Other 4 (2.7)
HIV status, no. (%)
Negative 52 (35.1)
Positive 96 (64.9)
CD4+ cell count/μL†
Median 47.5
Mean (range) 105 (1–589)
Previous tuberculosis, no. (%) 20 (13.5)
Previous MAC infection, no. (%)
10 (6.8)
No tuberculosis or MAC infection, no. (%) 118 (79.7)

*MAC, Mycobacterium avium complex.
†Data available for 90 of 96 HIV-infected patients.

Main Article

Page created: April 23, 2012
Page updated: April 23, 2012
Page reviewed: April 23, 2012
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.